Liver Injury in COVID-19: Caution and Management

The postmortem biopsies of a COVID-19 patient showed mild lobular and portal activity, and moderate microvascular steatosis, which indicated that liver injury was SARS-CoV-2 infection-related or drug-related [2]. [...]clinicians should concentrate on liver injury and monitoring liver function in COVID-19 patients. [...]considering the immunocompromised status, intensive surveillance and individually tailored therapy are appropriate for the above patients. Even if the COVID-19 RT-PCR test was negative during the treatment, it may be positive later due to the rise of viral load as the dosage of immunosuppression medicine was increased. [...]strict screening guidance and prolonged follow-up should be offered for liver recipients with COVID-19 infection.